FULC
Fulcrum Therapeutics, Inc.NASDAQHealthcare$8.04+7.49%ClosedMarket Cap: $435.1M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
4
Sales
3
Buy/Sell Ratio
1.33
Total Bought
$0.00
Total Sold
$3.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Feb 04 | Gould Robert J | director | Sell | 15,000 | $10.87 | 469,864 |
| Wed Feb 04 | Musso Alan A | officer: Chief Financial Officer | Sell | 170,000 | $10.72 | 170,000 |
| Wed Feb 04 | Oltmans Curtis Gale | officer: Chief Legal Officer | Sell | 170,000 | $10.72 | 170,000 |
| Wed Feb 04 | Tourangeau Greg | officer: Principal Accounting Officer | Sell | 57,000 | $10.72 | 57,000 |
| Wed Feb 04 | Sapir Alex | director, officer: See Remarks | Sell | 650,000 | $10.72 | 650,000 |
| Tue Jan 06 | Gould Robert J | director | Sell | 15,000 | $11.87 | 469,864 |
| Wed Dec 17 | Oltmans Curtis Gale | officer: Chief Legal Officer | Sell | 3,452 | $12.92 | 10,252 |
| Wed Dec 10 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Sell | 1,377,020 | $13.33 | 8,852,079 |
| Wed Dec 10 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Sell | 2,706,397 | $14.28 | 6,145,682 |